Search by Drug Name or NDC

NDC 68180-0741-02 Silodosin 8 mg/1 Details

Silodosin 8 mg/1

Silodosin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is SILODOSIN.

MedlinePlus Drug Summary

Silodosin is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia; BPH), which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency. Silodosin is in a class of medications called alpha-blockers. It relieves the symptoms of BPH by relaxing the muscles of the bladder and prostate.

Related Packages: 68180-0741-02
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Silodosin

Product Information

NDC	68180-0741
Product ID	68180-741_ea8e8335-ff34-45ba-b81a-68ec9d74e34f
Associated GPIs	56852060000140
GCN Sequence Number	064847
GCN Sequence Number Description	silodosin CAPSULE 8 MG ORAL
HIC3	Q9B
HIC3 Description	BENIGN PROSTATIC HYPERTROPHY/MICTURITION AGENTS
GCN	16858
HICL Sequence Number	036119
HICL Sequence Number Description	SILODOSIN
Brand/Generic	Generic
Proprietary Name	Silodosin
Proprietary Name Suffix	n/a
Non-Proprietary Name	Silodosin
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	8
Active Ingredient Units	mg/1
Substance Name	SILODOSIN
Labeler Name	Lupin Pharmaceuticals, Inc.
Pharmaceutical Class	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA206541
Listing Certified Through	2024-12-31

Package

NDC 68180-0741-02 (68180074102)

Pricing Information	N/A
NDC Package Code	68180-741-02
Billing NDC	68180074102
Package	500 CAPSULE in 1 BOTTLE (68180-741-02)
Marketing Start Date	2018-12-03
NDC Exclude Flag	N